Zdrowie i gospodarka · 30/05/2008

FDA to Reclassify Certain PTCA Catheters from Class III to Class II

The Food and Drug Administration (FDA) is seeking public comment on a recommendation to reclassify certain Percutaneous Transluminal Coronary Angioplasty (PTCA) catheters from class III to class II, following a petition from Cook Group Inc. (COOK) and review of publicly available information. The FDA will consider public comments before making a final decision on the reclassification.